Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00075179 · ClinicalTrials.gov registry record · Phase 4
Natrecor in Pulmonary Hypertension
A Phase 4 study, sponsored by M.D. Anderson Cancer Center.
- Terminated
- Registry status
- Phase 4
- Development phase
- 15
- Enrollment target
NCT00075179: Clinical Trial Phase 4 study, sponsored by M.D. Anderson Cancer Center.
NCT00075179 is a Phase 4 study that was terminated before completion, run by M.D. Anderson Cancer Center. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00075179, a Phase 4 study, was terminated before completion, sponsored by M.D. Anderson Cancer Center.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 15 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to learn if the drug nesiritide (Natrecor) is effective in lowering the pressure in your lungs. The primary objective of this study is to establish that Nesiritide (Natrecor) is effective in reducing pulmonary hypertension (PHTN) acutely as measured by a 20% reduction in the mean pulmonary arterial (PA) pressure. The secondary objectives will include: improvement in pulmonary vascular resistance (PVR), patient symptoms, exercise tolerance, frequency of toxicity, and surgeon's willingness to proceed with operation.
Interventions
- PROCEDURE Right Heart Catheterization
- DRUG Nesiritide (Natrecor)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2003-12-31 |
| Est. Completion | 2006-03-28 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00075179
The ClinicalTrials.gov registry entry for NCT00075179 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Right Heart Catheterization is the first listed.
NCT00075179 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00075179 about?
NCT00075179 is a clinical study titled "Natrecor in Pulmonary Hypertension". The goal of this clinical research study is to learn if the drug nesiritide (Natrecor) is effective in lowering the pressure in your lungs. The primary objective of this study is to establish that Nesiritide (Natrecor) is effective in reducing pulmonary hypertension (PHTN) acutely as measured by a ...
What is the current status of trial NCT00075179?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 15 participants. The study started on 2003-12-31. Estimated completion is 2006-03-28.
What interventions are being tested in trial NCT00075179?
The interventions under investigation include: Right Heart Catheterization (PROCEDURE), Nesiritide (Natrecor) (DRUG).
Who is sponsoring clinical trial NCT00075179?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.